C1292856||stimulate
C1321023||bone healing
C0005972||regeneration
C0242184||hypoxic conditions
C4019433||photobiomodulation
C0025219||melatonin
C0025219||Melatonin
C3179309||anabolic effects
C0391978||bone
C0242184||hypoxia
C1159974||osteoblastic differentiation
C2603343||study
C0025219||melatonin
C1159974||osteoblastic differentiation
C2350989||mineralization
C0242184||hypoxic conditions
C0007634||MC3T3-E1 cells
C0860755||oxygen tension
C0242184||hypoxia condition
C0007634||cells
C1159974||osteoblast differentiation
C0010454||medium
C0242184||hypoxic condition
C0025219||melatonin
C0025219||melatonin
C0020985||Immunoblotting
C1312518||osterix
C1171362||expression
C0025219||melatonin
C0007634||cells
C0002059||alkaline phosphatase
C0681814||experiment
C1318906||Alizarin Red staining
C2350989||mineralized
C0035441||nodules
C0025219||melatonin
C0007634||cells
C0025219||melatonin
C0007634||cells
C0007589||differentiation
C2350989||mineralization
C0007634||cells
C1120843||p38 MAPK
C2987025||PRKD1
C0037083||signaling mechanisms
C0025219||melatonin
C0007634||cells
C0065275||luzindole
C2917356||melatonin receptor antagonist
C0025219||melatonin
C0007589||differentiation
C2350989||mineralization
C0007634||MC3T3-E1 cells
C0242184||hypoxic conditions
C0065911||melatonin 1/2 receptors
C2987025||PKRD
C1120843||p38
C0037080||signaling pathways